King of Prussia’s SEED Therapeutics is tackling one of medicine’s toughest challenges, writes Holly Quinn for Technical.ly.
“For Spring/Summer 2026, we were thinking about the complexity of women and different facets of their style. Femininity and strength, precision and imperfection. The clash of pristine tailoring with ...